ZYNERBA PHARMACEUTICALS INC's ticker is ZYNE and the CUSIP is 98986X109. A total of 80 filers reported holding ZYNERBA PHARMACEUTICALS INC in Q1 2020. The put-call ratio across all filers is 2.65 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $96,000 | -36.4% | 131,036 | -1.0% | 0.01% | -43.5% |
| Q2 2022 | $151,000 | -51.1% | 132,405 | -12.3% | 0.02% | -43.9% |
| Q1 2022 | $309,000 | -60.4% | 150,914 | -44.3% | 0.04% | -58.2% |
| Q4 2021 | $780,000 | +445.5% | 270,772 | +701.4% | 0.10% | +553.3% |
| Q3 2021 | $143,000 | +6.7% | 33,788 | +52.8% | 0.02% | -6.2% |
| Q4 2019 | $134,000 | -24.3% | 22,106 | +1.9% | 0.02% | +60.0% |
| Q3 2018 | $177,000 | -63.6% | 21,700 | -44.1% | 0.01% | -66.7% |
| Q4 2017 | $486,000 | +162.7% | 38,800 | +256.0% | 0.03% | +150.0% |
| Q2 2017 | $185,000 | -70.1% | 10,900 | -64.6% | 0.01% | -63.6% |
| Q1 2017 | $619,000 | +189.3% | 30,800 | +124.8% | 0.03% | +153.8% |
| Q4 2016 | $214,000 | – | 13,700 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ETF MANAGERS GROUP, LLC | 2,679,457 | $20,257,000 | 0.73% |
| Portolan Capital Management | 777,293 | $5,876,000 | 0.66% |
| CAMPBELL CAPITAL MANAGEMENT INC | 110,451 | $835,000 | 0.62% |
| ZEKE CAPITAL ADVISORS, LLC | 402,212 | $3,041,000 | 0.27% |
| Leap Investments LP | 46,084 | $348,000 | 0.17% |
| Bernardo Wealth Planning LLC | 26,419 | $199,000 | 0.14% |
| Claraphi Advisory Network, LLC | 14,744 | $111,000 | 0.07% |
| Sterling Investment Advisors, Ltd. | 11,000 | $83,000 | 0.04% |
| A.R.T. Advisors, LLC | 81,372 | $615,000 | 0.03% |
| Mirae Asset Global Investments Co., Ltd. | 544,408 | $4,116,000 | 0.03% |